These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12125951

  • 1. Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment.
    Chu CY, Yang CH, Chiu HC.
    Acta Derm Venereol; 2002; 82(2):147-8. PubMed ID: 12125951
    [No Abstract] [Full Text] [Related]

  • 2. Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.
    Chu CY, Yang CH, Yang CY, Hsiao GH, Chiu HC.
    Br J Dermatol; 2000 Apr; 142(4):808-11. PubMed ID: 10792238
    [Abstract] [Full Text] [Related]

  • 3. [Gemcitabine-based combinations in inoperable pancreatic cancers].
    Louvet C, André T, Artru P.
    Bull Cancer; 2002 Aug; 89 Spec No():S96-101. PubMed ID: 12449038
    [Abstract] [Full Text] [Related]

  • 4. [A case of docetaxel-resistant lung cancer effectively treated with chemotherapy of gemcitabine and vinorelbine].
    Daido K, Arita K, Ohashi N, Nakamura K.
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1747-50. PubMed ID: 11057328
    [Abstract] [Full Text] [Related]

  • 5. Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.
    Chen GY, Chang TW, Chen WC.
    Br J Dermatol; 2003 May; 148(5):1071-3. PubMed ID: 12786853
    [No Abstract] [Full Text] [Related]

  • 6. Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
    Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP.
    Cancer; 2001 Dec 01; 92(11):2902-10. PubMed ID: 11753965
    [Abstract] [Full Text] [Related]

  • 7. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y.
    Cancer Chemother Pharmacol; 2003 Jul 01; 52(1):19-24. PubMed ID: 12712259
    [Abstract] [Full Text] [Related]

  • 8. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Burris HA, Billings FT, Bradof JE, Baker M, Greco FA.
    Cancer; 2001 Nov 01; 92(9):2391-8. PubMed ID: 11745295
    [Abstract] [Full Text] [Related]

  • 9. Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: a phase I study.
    Frassineti GL, Ibrahim T, Zoli W, Monti M, Ricotti L, Nanni O, Amadori D.
    Tumori; 2002 Nov 01; 88(2):99-103. PubMed ID: 12088266
    [Abstract] [Full Text] [Related]

  • 10. Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.
    Zimmerman GC, Keeling JH, Lowry M, Medina J, Von Hoff DD, Burris HA.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):557-8. PubMed ID: 7907667
    [No Abstract] [Full Text] [Related]

  • 11. [Docetaxel].
    Takigawa N.
    Nihon Rinsho; 2002 May 06; 60 Suppl 5():349-52. PubMed ID: 12101686
    [No Abstract] [Full Text] [Related]

  • 12. A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.
    Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW.
    Cancer; 2000 Jan 01; 88(1):180-5. PubMed ID: 10618622
    [Abstract] [Full Text] [Related]

  • 13. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.
    Schneeweiss A, Huober J, Sinn HP, von Fournier D, Rudlowski C, Beldermann F, Krauss K, Solomayer E, Hamerla R, Wallwiener D, Bastert G.
    Eur J Cancer; 2004 Nov 01; 40(16):2432-8. PubMed ID: 15519516
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.
    Fleming DR, Glisson SD, Bhupalam L, Michelson GD, Goldsmith GH, LaRocca RV.
    Am J Clin Oncol; 2000 Aug 01; 23(4):349-52. PubMed ID: 10955861
    [Abstract] [Full Text] [Related]

  • 15. A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma.
    Popa IE, Stewart K, Smith FP, Rizvi NA.
    Cancer; 2002 Oct 15; 95(8):1714-9. PubMed ID: 12365019
    [Abstract] [Full Text] [Related]

  • 16. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
    Brugnatelli S, Danova M, De Bella MT, Vaglica M, Manuguerra G, Riccardi A, Palmeri S.
    Oncology; 2002 Oct 15; 62(1):33-8. PubMed ID: 11810041
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].
    Rinaldi M.
    Tumori; 2001 Oct 15; 87(6):A6-9. PubMed ID: 11995708
    [No Abstract] [Full Text] [Related]

  • 20. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.
    Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Palamidas P, Vlachonikolis I, Greek Oncology Cooperative Group (GOCG) for Lung Cancer.
    Lancet; 2001 May 12; 357(9267):1478-84. PubMed ID: 11377599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.